ABSTRACT
Purpose
Stability of polymeric micelles upon injection is essential for a drug delivery system but is not fully understood. We optimized an analytical test allowing quantification of micellar stability in biofluids and applied it to a variety of block copolymer micelles with different hydrophobic block architechtures.
Methods
Polymeric micelles were prepared from four different polymers and investigated via encapsulation of two fluorescent dyes. Samples were incubated in human serum; changes in Foerster Resonance Energy Transfer (FRET) were recorded as a function of time. This fluorescence-based approach was supported semi-quantitatively by results from Asymmetrical Flow Field-Flow-Fractionation (AF4).
Results
After incubation experiments, micellar stability was determined by calculation of two stability-indicating parameters: residual micellar fractions (RMFs) and in vitro serum half-lives. Both parameters showed that PEG-PVPy micelles rapidly destabilized after 3 h (RMF < 45%), whereas PEG-PLA, PEG-PLGA and PEG-PCL micelles were far more stable (RMFs 65 to 98%).
Conclusion
This FRET-based assay is a valuable tool in evaluating and screening serum stability of polymeric micelles and revealed low serum stability of PEG-PVPy micelles compared to polyester-based micelles.
Similar content being viewed by others
REFERENCES
Lipinski C. Poor aqueous solubility—an industry wide problem in drug discovery. Am Pharm Rev. 2002;5:82–5.
Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003;92:1343–55.
Jones M, Leroux J. Polymeric micelles—a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999;48:101–11.
Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113–31.
Aliabadi HM, Shahin M, Brocks DR, Lavasanifar A. Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery. Clin Pharmacokinet. 2008;47:619–34.
Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol. 2010;624:25–37.
Wiradharma N, Zhang Y, Venkataraman S, Hedrick JL, Yang YY. Self-assembled polymer nanostructures for delivery of anticancer therapeutics. Nano Today. 2009;4:302–17.
Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab. 2010;11:129–41.
Hamaguchi T. Cancer chemotherapy utilizing nanotechnology. Gan To Kagaku Ryoho. 2009;36:372–6.
Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan KS, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001;72:191–202.
Chung TW, Liu DZ, Hsieh JH, Fan XC, Yang JD, Chen JH. Characterizing poly(epsilon-caprolactone)-b-chitooligosaccharide-b-poly(ethylene glycol) (PCP) copolymer micelles for doxorubicin (DOX) delivery: effects of crosslinked of amine groups. J Nanosci Nanotechnol. 2006;6:2902–11.
Kim S, Shi Y, Kim JY, Park K, Cheng JX. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction. Expert Opin Drug Deliv. 2010;7:49–62.
Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release. 2010;143:2–12.
Chen H, Kim S, He W, Wang H, Low PS, Park K, et al. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir. 2008;24:5213–7.
Chen H, Kim S, Li L, Wang S, Park K, Cheng JX. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc Natl Acad Sci USA. 2008;105:6596–601.
Kamat PV, Fox MA. Photophysics and photochemistry of xanthene dyes in polymer-solutions and films. J Phys Chem. 1984;88:2297–302.
Cerritelli S, Velluto D, Hubbell JA, Fontana A. Breakdown kinetics of aggregates from poly(ethylene glycol-bl-propylene sulfide) di- and triblock copolymers induced by a non-ionic surfactant. J Polym Sci A Polym Chem. 2008;46:2477–87.
Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerf. 2000;18:301–13.
Aliabadi HM, Brocks DR, Mahdipoor P, Lavasanifar A. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers. J Control Release. 2007;122:63–70.
Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 2003;300:615–8.
Wilhelm M, Zhao CL, Wang YC, Xu RL, Winnik MA, Mura JL, et al. Poly(styrene-ethylene oxide) block copolymer micelle formation in water—a fluorescence probe study. Macromolecules. 1991;24:1033–40.
Kalyanasundaram K, Thomas JK. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J Am Chem Soc. 1977;99:2039–44.
Berney C, Danuser G. FRET or no FRET: a quantitative comparison. Biophys J. 2003;84:3992–4010.
Fraunhofer W, Winter G. The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics. Eur J Pharm Biopharm. 2004;58:369–83.
Zimm BH. The scattering of light and the radial distribution function of high polymer solutions. J Chem Phys. 1948;16:1093–9.
Zheng Z, Obbard JP. Evaluation of an elevated non-ionic surfactant critical micelle concentration in a soil/aqueous system. Water Res. 2002;36:2667–72.
Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B-Biointerf. 1999;16:3–27.
Wang L, Zeng R, Li C, Qiao R. Self-assembled polypeptide-block-poly(vinylpyrrolidone) as prospective drug-delivery systems. Colloids Surf B Biointerf. 2009;74:284–92.
Sagalowicz L, Leser ME, Watzke HJ, Michel M. Monoglyceride self-assembly structures as delivery vehicles. Trends Food Sci Technol. 2006;17:204–14.
European Medicines Agency. Reflection paper on the pharmaceutical development of intravenous medicinal products containing active substances solubilised in micellar systems (non-polymeric surfactants). EMA/CHMP/QWP/574767/2010 (2010).
Ahyayauch H, Bennouna M, Alonso A, Goni FM. Detergent effects on membranes at subsolubilizing concentrations: transmembrane lipid motion, bilayer permeabilization, and vesicle lysis/reassembly are independent phenomena. Langmuir. 2010;26:7307–13.
Lasseter KC, Gambale J, Jin B, Bergman A, Constanzer M, Dru J, et al. Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. J Clin Pharmacol. 2007;47:834–40.
Riley T, Govender T, Stolnik S, Xiong CD, Garnett MC, Illum L, et al. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloids Surf B-Biointerf. 1999;16:147–59.
Jacquin M, Muller P, Cottet H, Theodoly O. Self-assembly of charged amphiphilic diblock copolymers with insoluble blocks of decreasing hydrophobicity: from kinetically frozen colloids to macrosurfactants. Langmuir. 2010;26:18681–93.
Theodoly O, Jacquin M, Muller P, Chhun S. Adsorption kinetics of amphiphilic diblock copolymers: from kinetically frozen colloids to macrosurfactants. Langmuir. 2009;25:781–93.
Toncheva V, Schacht E, Ng SY, Barr J, Heller J. Use of block copolymers of poly(ortho esters) and poly (ethylene glycol) micellar carriers as potential tumour targeting systems. J Drug Target. 2003;11:345–53.
ACKNOWLEDGMENTS & DISCLOSURES
The authors thank Dr. Judith Kuntsche at the Martin Luther University Halle, Germany, for her help with the AF4 experiments. The support of Dr. Philip Hewitt and Alina Rwei, Merck KGaA Darmstadt, Germany, concerning language improvements is highly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, T., Rachel, R., Besheer, A. et al. Comparative Investigations on In Vitro Serum Stability of Polymeric Micelle Formulations. Pharm Res 29, 448–459 (2012). https://doi.org/10.1007/s11095-011-0555-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-011-0555-x